Cellular immune breadth of an Omicron-specific, self-amplifying monovalent mRNA vaccine booster for COVID-19NPJ VACCINESIF6.52025-03-010OAAI
An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial用于新型冠状病毒肺炎的Omicron特异性,自我扩增mRNA加强疫苗: 2/3期随机试验NATURE MEDICINEIF502024-04-185OAAI
Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: a sub-study of the NEAT001/ANRS143 randomized trialJOURNAL OF ANTIMICROBIAL CHEMOTHERAPYIF3.62019-11-215OAAI
Dual-stimuli responsive injectable microgel/solid drug nanoparticle nanocomposites for release of poorly soluble drugsNANOSCALEIF5.12017-01-0136OAAI
Accelerated oral nanomedicine discovery from miniaturized screening to clinical production exemplified by paediatric HIV nanotherapiesNATURE COMMUNICATIONSIF15.72016-10-2148OAAI